Rapid SARS-CoV-2 Virus Enrichment and RNA Extraction for Efficient Diagnostic Screening of Pooled Nasopharyngeal or Saliva Samples for Dilutions Up to 1:100

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Jun 24

PMID 35741208

Authors

Jamila S Marshall

Rachelle Turiello

Larissa L Cunha

Ella V Frazier

Jeff Hickey

Jeff Chapman

Melinda D Poulter

Heather L Fehling

James P Landers

Affiliations

Soon will be listed here.

Abstract

As COVID-19 transmission control measures are gradually being lifted, a sensitive and rapid diagnostic method for large-scale screening could prove essential for monitoring population infection rates. However, many rapid workflows for SARS-CoV-2 detection and diagnosis are not amenable to the analysis of large-volume samples. Previously, our group demonstrated a technique for SARS-CoV-2 nanoparticle-facilitated enrichment and enzymatic lysis from clinical samples in under 10 min. Here, this sample preparation strategy was applied to pooled samples originating from nasopharyngeal (NP) swabs eluted in viral transport medium (VTM) and saliva samples diluted up to 1:100. This preparation method was coupled with conventional RT-PCR on gold-standard instrumentation for proof-of-concept. Additionally, real-time PCR analysis was conducted using an in-house, ultra-rapid real-time microfluidic instrument paired with an experimentally optimized rapid protocol. Following pooling and extraction from clinical samples, average cycle threshold (C) values from resultant eluates generally increased as the pooling dilution factor increased; further, results from a double-blind study demonstrated 100% concordance with clinical values. In addition, preliminary data obtained from amplification of eluates prepared by this technique and analyzed using our portable, ultra-rapid real-time microfluidic PCR amplification instrument showed progress toward a streamlined method for rapid SARS-CoV-2 analysis from pooled samples.

References

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Bullard J, Dust K, Funk D, Strong J, Alexander D, Garnett L . Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples. Clin Infect Dis. 2020; 71(10):2663-2666. PMC: 7314198. DOI: 10.1093/cid/ciaa638. View

da Silva R, Marinho L, Silva D, de Lima K, Pirih F, Martins A . Saliva as a possible tool for the SARS-CoV-2 detection: A review. Travel Med Infect Dis. 2020; 38:101920. PMC: 7674016. DOI: 10.1016/j.tmaid.2020.101920. View

Moreno-Contreras J, Espinoza M, Sandoval-Jaime C, Cantu-Cuevas M, Madrid-Gonzalez D, Baron-Olivares H . Pooling saliva samples as an excellent option to increase the surveillance for SARS-CoV-2 when re-opening community settings. PLoS One. 2022; 17(1):e0263114. PMC: 8789121. DOI: 10.1371/journal.pone.0263114. View

Fredrickson C, Fan Z . Macro-to-micro interfaces for microfluidic devices. Lab Chip. 2004; 4(6):526-33. DOI: 10.1039/b410720a. View

Sule W, Oluwayelu D . Real-time RT-PCR for COVID-19 diagnosis: challenges and prospects. Pan Afr Med J. 2020; 35(Suppl 2):121. PMC: 7687508. DOI: 10.11604/pamj.supp.2020.35.24258. View

Cherif A, Grobe N, Wang X, Kotanko P . Simulation of Pool Testing to Identify Patients With Coronavirus Disease 2019 Under Conditions of Limited Test Availability. JAMA Netw Open. 2020; 3(6):e2013075. PMC: 7315509. DOI: 10.1001/jamanetworkopen.2020.13075. View

Chong B, Tran T, Druce J, Ballard S, Simpson J, Catton M . Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings. Pathology. 2020; 52(7):796-800. PMC: 7508550. DOI: 10.1016/j.pathol.2020.09.005. View

10.

Nouwairi R, Cunha L, Turiello R, Scott O, Hickey J, Thomson S . Ultra-rapid real-time microfluidic RT-PCR instrument for nucleic acid analysis. Lab Chip. 2022; 22(18):3424-3435. PMC: 9474628. DOI: 10.1039/d2lc00495j. View

11.

Ravi N, Cortade D, Ng E, Wang S . Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape. Biosens Bioelectron. 2020; 165:112454. PMC: 7368663. DOI: 10.1016/j.bios.2020.112454. View

12.

Esbin M, Whitney O, Chong S, Maurer A, Darzacq X, Tjian R . Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA. 2020; 26(7):771-783. PMC: 7297120. DOI: 10.1261/rna.076232.120. View

13.

Dignan L, Turiello R, Layne T, OConnell K, Hickey J, Chapman J . An ultrafast SARS-CoV-2 virus enrichment and extraction method compatible with multiple modalities for RNA detection. Anal Chim Acta. 2021; 1180:338846. PMC: 8277111. DOI: 10.1016/j.aca.2021.338846. View

14.

Tukey J . Comparing individual means in the analysis of variance. Biometrics. 1949; 5(2):99-114. View

15.

Grobe N, Cherif A, Wang X, Dong Z, Kotanko P . Sample pooling: burden or solution?. Clin Microbiol Infect. 2021; 27(9):1212-1220. PMC: 9477502. DOI: 10.1016/j.cmi.2021.04.007. View

16.

Arena F, Pollini S, Rossolini G, Margaglione M . Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic. Int J Mol Sci. 2021; 22(3). PMC: 7865767. DOI: 10.3390/ijms22031298. View

17.

Dong X, Liu L, Tu Y, Zhang J, Miao G, Zhang L . Rapid PCR powered by microfluidics: A quick review under the background of COVID-19 pandemic. Trends Analyt Chem. 2021; 143:116377. PMC: 8223007. DOI: 10.1016/j.trac.2021.116377. View

18.

Barat B, Das S, De Giorgi V, Henderson D, Kopka S, Lau A . Pooled Saliva Specimens for SARS-CoV-2 Testing. J Clin Microbiol. 2020; 59(3). PMC: 8106731. DOI: 10.1128/JCM.02486-20. View